Cancer detection kit, which fuses molecular diagnostics with nanotechnology Acrongenomics Inc. Has introduced a revolutionary design of its nanobiotechnology item, the Neo-EpCAM tumor detection package, which fuses molecular diagnostics with nanotechnology. The Neo-EpCAMTM kit will be used for the recognition of cancers of epithelial origin such as, lung, breasts, colon, prostate, neck and head, tummy, ovary, pancreas, oesophagus, and larynx. Related StoriesMD Anderson study reveals why chemotherapy drugs not effective for most pancreatic cancers patientsNew antenna-like gadget makes breast cancer surgery easier for surgeonsMeat-rich diet plan may increase kidney tumor riskThe Neo-EpCAM tumor detection kit can be performed on the most commonly used technological system, the PCR , for molecular diagnostics.PT001 and PT005 were in comparison to placebo also. In PINNACLE 1, open-label tiotropium was included as a dynamic control. Both research were conducted over 24 weeks in topics with COPD. The principal objective of both research was improvement in lung work as assessed by trough pressured expiratory volume in a single second . PINNACLE 3 was a multi-center, randomised, double-blind, parallel-group, chronic dosing, active-managed, 28-week safety extension research of both pivotal 24-week research . It had been designed to measure the long-term security, tolerability, and efficacy of PT003 administered twice daily via pMDI in comparison to PT001 and PT005 in individuals with moderate to extremely serious COPD over a complete observation amount of 52 weeks.